Evidence map›Paper›PMID 29753618›Full record

ArticleThe Journal of arthroplasty2018

Predictors and Cost of Readmission in Total Knee Arthroplasty.

Kenneth L Urish, Yongmei Qin, Benjamin Y Li, Tudor Borza, Michael Sessine, Peter Kirk, Brent K Hollenbeck, Jonathan E Helm, Mariel S Lavieri, Ted A Skolarus and 1 more

Abstract read
In one paragraph

Article in The Journal of arthroplasty, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Heart failure patients demonstrate excellent 1-year outcomes after total knee arthroplasty despite high healthcare utilization.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Early Readmission and Revision After Total Joint Arthroplasty: An Analysis of Cause and Cost.HSS journal : the musculoskeletal journal of Hospital for Special Surgery · 2024
    Article
  11. Review
  12. Article
  13. Cost-effectiveness of patient specificWorld journal of orthopedics · 2023
    Article
  14. Article
  15. Unplanned Emergency and Urgent Care Visits After Outpatient Orthopaedic Surgery.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kenneth L UrishArthritis and Arthroplasty Design Group, The Bone and Joint Center, Magee Womens Hospital of the University of Pittsburgh Medical Center; Department of Orthopaedic Surgery, Department of Bioengineering, and Clinical and Translational Science Institute, University of Pittsburgh; Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania.
Yongmei QinDivision of Oncology, Dow Division for Urologic Health Service Research, Department of Urology, University of Michigan, Ann Arbor, Michigan.
Benjamin Y LiDivision of Oncology, Dow Division for Urologic Health Service Research, Department of Urology, University of Michigan, Ann Arbor, Michigan.
Tudor BorzaDivision of Oncology, Dow Division for Urologic Health Service Research, Department of Urology, University of Michigan, Ann Arbor, Michigan.
Michael SessineDivision of Oncology, Dow Division for Urologic Health Service Research, Department of Urology, University of Michigan, Ann Arbor, Michigan.
Peter KirkDivision of Oncology, Dow Division for Urologic Health Service Research, Department of Urology, University of Michigan, Ann Arbor, Michigan.
Brent K HollenbeckDivision of Oncology, Dow Division for Urologic Health Service Research, Department of Urology, University of Michigan, Ann Arbor, Michigan.
Jonathan E HelmHealth Services Research & Development, Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan.
Mariel S LavieriDepartment of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan.
Ted A SkolarusDepartment of Urology, Division of Oncology, Dow Division for Urologic Health Service Research, Health Services Research & Development, Center for Clinical Management Research, VA Ann Arbor Healthcare System, University of Michigan, Ann Arbor, Michigan.
Bruce L JacobsDepartment of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania.

Funding

Institutional Career Development CoreKL2TR001856 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RAY, KRISTIN N, RUBIO, DORIS M · 2016 to 2025
$13.8M
University of Pittsburgh Clinical and Translational Science InstitutionKL2TR000146 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$8.7M
Advanced Training in Urologic OncologyT32CA180984 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ganesh S Palapattu, VAHAKN B SHAHINIAN · 2014 to 2026
$3.4M
Ambulatory Surgery Centers and Medicare Expenditures for Outpatient ProceduresR01HS018726 · AHRQ · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLLENBECK, BRENT K. · 2010 to 2013
$1.8M
Impact of Urologist Practice Structure on Prostate Cancer CareR01CA168691 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HOLLENBECK, BRENT K., SHAHINIAN, VAHAKN B · 2013 to 2016
$1.6M
Biofilm antibiotic tolerance in periprosthetic joint infectionK08AR071494 · NIAMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI URISH, KENNETH L · 2017 to 2021
$831k
Enriching Claims-Based Analysis of Prostate Cancer Treatment Decision MakingR03AG048091 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JACOBS, BRUCE L. · 2014 to 2015
$228k
AHRQ HHS R01 HS018726NCATS NIH HHS KL2 TR000146NCATS NIH HHS KL2 TR001856NCI NIH HHS R01 CA168691NCI NIH HHS T32 CA180984NIAMS NIH HHS K08 AR071494NIA NIH HHS R03 AG048091
6 · The paper itself

Abstract

backgroundThe Comprehensive Care for Joint Replacement bundle was created to decrease total knee arthroplasty (TKA) cost. To help accomplish this, there is a focus on reducing TKA readmissions. However, there is a lack of national representative sample of all-payer hospital admissions to direct strategy, identify risk factors for readmission, and understand actual readmission cost.

methodsWe used the Nationwide Readmission Database to examine national readmission rates, predictors of readmission, and associated readmission costs for elective TKA procedures. We fit a multivariable logistic regression model to examine factors associated with readmission. Then, we determined mean readmission costs and calculated the readmission cost when distributed across the entire TKA population.

resultsWe identified 224,465 patients having TKA across all states participating in the Nationwide Readmission Database. The mean unadjusted 30-day TKA readmission rate was 4%. The greatest predictors of readmission were congestive heart failure (odds ratio [OR] 2.51, 95% confidence interval [CI] 2.62-2.80), renal disease (OR 2.19, 95% CI 2.03-2.37), and length of stay greater than 4 days (OR 2.4, 95% CI 2.25-2.61). The overall median cost for each readmission was $6753 ± 175. Extrapolating the readmission cost for the entire TKA population resulted in the readmission cost being 2% of the overall 30-day procedure cost.

conclusionsA major focus of the Comprehensive Care for Joint Replacement bundle is improving cost and quality by limiting readmission rates. TKA readmissions are low and comprise a small percentage of total TKA cost, suggesting that they may not be the optimal measure of quality care or a significant driver of overall cost.

Indexed as

AgedAged, 80 and overArthroplasty, Replacement, KneeDatabases, FactualFemaleHealth Care CostsHumansLogistic ModelsMaleMedicareMiddle AgedMultivariate AnalysisOdds RatioPatient ReadmissionQuality of Health CareRisk FactorsComprehensive Care for Joint ReplacementNationwide Readmission Databasereadmissionreadmission costtotal knee arthroplasty

Identifiers

PMID29753618
PMCPMC6103832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.